40 likes | 118 Views
ATTENDANCE FORM 8th NORTH WEST DIABETES & CARDIOVASCULAR DISEASE UPDATE 8 th May 2013 Free entry for healthcare professionals. Limited number of places available. To reserve your place, please complete the form and return at your earliest convenience to:
E N D
ATTENDANCE FORM 8th NORTH WEST DIABETES & CARDIOVASCULAR DISEASE UPDATE 8th May 2013 Free entry for healthcare professionals. Limited number of places available. To reserve your place, please complete the form and return at your earliest convenience to: Email: mark.woodcock@cmft.nhs.uk (preferred method of reply, with information requested below) Fax: 0161 276 4684 (f.a.o. Mark Woodcock) Phone: 0161 276 8946 Post: Mark Woodcock, Cardiovascular Trials Unit, Central Manchester University Hospitals NHS Foundation Trust, Ground Floor, Old St Mary's Building, Hathersage Road, Manchester, M13 9WL. [ ] Yes, I am able to attend the meeting on Wednesday 8th May 2013 [ ] I would like to be contacted for future events CORRESPONDENCE DETAILS Title: ……………………….. Position:………………………………………………………………….. Name: …………………………………………………………………………………………………………. GP Surgery/Hospital: .…….…………………………………………………………………………………. Address: ……………………………………………………………………………………………………….. …………………………………………………………………………………………………………………… …………………………………………………………………………………………………………………… Postcode: ……………………………………………………………………………..................................... Daytime Tel: ……………………………………………Mobile: ………….……….................................... Email Address( required for confirmation and reminder): ………………………………………………… Please state any dietary requirements: ……………………………………………………………………. Signature: …………………………………………………………………………………………………………… Date: …………………………………………………………………………………………………………… The personal data and sensitive personal data (as defined by the Data Protection Act 1998) supplied by you in response to this form is required for accommodation, registration and associated records keeping purposes relating to the above event. By completing and returning this form, you agree that this data may be used, disclosed and held on a ‘need to know’ basis for these purposes by the organisers.
Invitation DIABETES & CARDIOVASCULAR UPDATE 8th NORTH WEST Wednesday 8th May 2013 9am to 4pm De Vere Whites, Reebok Stadium, De Havilland Way, Bolton, BL6 6SF Organised by Dr Handrean Soran & Dr Naveed Younis The organisers will not receive speaker honorarium or any other fee for chairing the sessions and organising the meeting CPD accreditation (5 points) applied for University of Manchester The Centre for Endocrinology & Diabetes This meeting has been funded by Bristol-Myers Squibb and AstraZeneca, who had no input into speaker selection and content.
DIABETES & CARDIOVASCULAR UPDATE A distinguished faculty of experts welcomes you to join them at the eighth North West diabetes and cardiovascular disease update meeting Professor Clifford Bailey, Dr Jennifer Beynon, Dr Farzin Fath-Ordoubadi, Professor Peter Grant, Dr Miles Riddle, Dr Handrean Soran & Dr Naveed Younis 8Th NORTH WEST We look forward to meeting you at this event • Educational objectives • Aim of session 1, • The aim of this session is to review management of type 1 diabetes, challenges and therapeutic options. The speaker will also address individualising insulin choice and regimens. The second talk will focus on managing diabetes in the peadiatric population and the inherent challenges • Aim of session 2 • The first talk will provide a review and an update on new therapeutic options for type 2 diabetes and their role in patient management. The speaker will also provide an update on the place of these new guidelines in the management of type 2 diabetes. • The second talk will focus on difficult cases in the management of Type 2 diabetes. • Aim of session 3 • This session covers and updates on hyperlipidaemia, macrovascular complications of type 2 diabetes. • The first talk is on macrovascular disease in type 2 diabetes. This talk will explores the impact of glycaemic control, lipid modification therapy and lowering blood pressure on prevention of macrovascular disease in type 2 diabetes. • The second talk will provide a review and an update on management of hyperlipidaemia and recent trials outcomes. The speaker will also present an update on national and international guidelines. The talk will include interactive case based discussions. • The third talk addresses the prevalence of coronary heart disease in patients with type 2 diabetes, when to investigate and refer to cardiology clinics. Management and challenges facing cardiologists will also be discussed.
0830 – 0920 Registration 09.20 – 09.30 Welcome Handrean Soran Session 1 Chair Dr Naveed Younis 0930 – 1010 Management options of type 1 diabetes; challenges and therapeutic options. An interactive case based discussion. Dr Jenny Beynon, Consultant Physician, University Hospital South Manchester. Q&A session 1010 – 1050 Challenges in managing Paediatric Diabetes Dr Miles Riddle, Consultant Paediatrician, University Hospital South Manchester. Q&A session 1050 – 1120 Tea & Coffee Session 2 Chair Dr Handrean Soran 1120 – 1200 New therapeutic agents and their place in guidelines and management of type 2 diabetes. Professor Clifford Bailey, Aston University, Birmingham, UK Q&A session 12.00 – 12.40 Type 2 diabeets: selecting the right treatment for the right patient. Dr Naveed Younis , Consultant Physician, University Hospital South Manchester. Q&A session 12.40 - 13.50 Lunch & Networking Session 3 Chair Dr Naveed Younis 1350 – 1430 Prevention of Cardiovascular Disease in Diabetes: Is Glucose Lowering Enough? Professor Peter Grant, Leeds University, Leeds, UK. Q&A session 1430 – 15.10 Hyperlipidaemia: what is new? Dr Handrean Soran, Consultant Physician and Endocrinologist, Central Manchester University Hospitals NHS Foundation Trust. Q&A 1510 – 1550 Coronary heart disease in patients with diabetes and dysglycaemia: diagnosis, management and challenges. Dr Farzin Fath-Ordoubadi, Consultant Cardiologist, Central Manchester University Hospitals NHS Foundation Trust Q&A session 1550 -1600 Summary and close Agenda